tiprankstipranks
Trending News
More News >
Shanghai Fosun Pharmaceutical (Group) Co Class H (SFOSF)
:SFOSF

Shanghai Fosun Pharmaceutical (Group) Co (SFOSF) Revenue

Compare
22 Followers

Shanghai Fosun Pharmaceutical (Group) Co Revenue

Shanghai Fosun Pharmaceutical (Group) Co had a revenue of 9.42B in the quarter ending Mar 31, 2025, with -7.24%. This bring the company's revenue in the last twelve months to 40.33B, Increased -1.79%. In the fiscal year ending Dec 31, 2024, Shanghai Fosun Pharmaceutical (Group) Co had annual revenue of 41.07B with -0.80% growth.
Revenue (ttm)
40.33B
Revenue Growth
P/S Ratio
0.22
Revenue/Employee
$1,012,580
Employees
40,557
Market Cap
$8.87B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
41.07B-332.34M-0.80%
Dec 31, 2023
41.40B-2.55B-5.81%
Dec 31, 2022
43.95B4.95B+12.68%
Dec 31, 2021
39.01B8.70B+28.70%
Dec 31, 2020
30.31B1.72B+6.02%
Dec 31, 2019
28.59B3.67B+14.72%
Dec 31, 2018
24.92B6.38B+34.45%
Dec 31, 2017
18.53B3.90B+26.69%
Dec 31, 2016
14.63B
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis